SIGNIFICANT ROLE OF SMALL RESPIRATORY TRACTS: NEW POSSIBILITIES OF CYCLESONIDE IN THERAPY OF BRONCHIAL ASTHMA
https://doi.org/10.21518/2079-701X-2017-18-56-60
Abstract
The review considers the importance of small airways in the development of the pathological process in bronchial asthma, the effect of dysfunction of small bronchi on the symptoms of asthma, the frequency of exacerbations, and disease control. The role of small airways as a target for anti-inflammatory therapy, the possibility of using fine-dispersed aerosols in the treatment of asthma, the features of clinical pharmacology, clinical effects and the safety of modern inhaled corticosteroid ciclesonides are discussed in detail.
About the Author
R. S. Fassakhov
Institute of Fundamental Medicine and Biology of Kazan (Privolzhsky) Federal University
Russian Federation
Russian Federation
MD, Institute of Fundamental Medicine and Biology
References
1. Hyde D et al. Anatomy, pathology and physiology of the tracheobronchial tree: Emphasis on the distal airways. J. Allergy and Clin. Immunology, 2009, 124: S72-S77.
2. Lipworth B, Manoharan A, Anderson W. Unlocking the quiet zone: the small airway asthma phenotype. Lancet Respir Med, 2014, 2: 497-506.
3. Perez T et al. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med, 2013, 107(11): 1667-1674.
4. Mahut B et al. Gas trapping is associated with severe exacerbation in asthmatic children. Respir Med, 2010, 104: 1230–1233.
5. Busacker A et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest, 2009, 135: 48-56.
6. Anderson WJ, Zajda E, Lipworth BJ. Are we overlooking persistent small airways dysfunction in community-managed asthma? Ann Allergy Asthma Immunol, 2012, 109: 185-189.
7. Usmani OS, Singh D, Spinola M, Bizzi A, Barnes PJ. The prevalence of small airways disease in adult asthma: a systematic literature review. Respir Med, 2016, 116: 19-27.
8. Perez T, Chanez P, Dusser D, Devillier P. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med, 2013 Nov, 107(11): 1667-1674.
9. Wennergren G, Gustafsson P. Small airway function, exhaled NO and airway hyper-responsiveness in paediatric asthma. Respir Med, 2011, 105(10): 1476-1484.
10. Schiphof-Godart L et al. Development of a tool to recognize small airways dysfunction in asthma (SADT). Health Qual Life Outcomes, 2014 Nov 22, 12: 155.
11. Kaminsky DA, Irvin CG, Gurka DA, et al. Peripheral airway responsiveness to cool, dry air in normal and asthmatic individuals. Am J Respir Crit Care Med, 1995, 152: 1784-1790.
12. Alfieri V et al. Small airway dysfunction is associated to excessive bronchoconstriction in asthmatic patients. Respir Res, 2014, 15(1): 86.
13. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Am J Respir Crit Care Med, 1996, 154: 1505-1510.
14. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Eur Respi J, 2002, 20: 841-845.
15. Rao DR et al. The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma, 2012, 49: 586-592.
16. Mahut B et al. Gas trapping is associated with severe exacerbation in asthmatic children. Respir Med., 2010, 104: 1230-1233.
17. Takeda T et al. Relationship between Small Airway Function and Health Status, Dyspnea and Disease Control in Asthma. Respiration, 2010, 80: 120-126.
18. Pisi R et al. Small airway dysfunction by impulse oscillometry in asthmatic patients with normal forced expiratory volume in the 1st second values. Allergy Asthma Proc, 2013, 34(1): e14-20.
19. Manoharan A et al. Small airway dysfunction is associated with poorer asthma control. Eur Respir J, 2014, 44(5): 1353-1355.
20. Bacharier LB et al. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med, 2004, 170(4): 426-32.
21. Rao DR et al. The utility of forced expiratory flow between 25 % and 75 % of vitalcapacity in predicting childhood asthma morbidity and severity. J Asthma, 2012, 49: 586-592.
22. Shi Y et al. Relating small airways to asthma control by using impulseoscillometry in children. J Allergy Clin Immunol, 2012, 129: 671-678.
23. Shi Y, Aledia AS, Galant SP, George SC. Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children. J Allergy Clin Immunol, 2013, 131: 718-723.
24. Labiris N, Dolovich M. Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol, 2003 Dec, 56(6): 588-599.
25. Chrystyn H. Anatomy and physiology in delivery: can we define our targets? Allergy, 1999, 54(suppl 49): 82-87.
26. Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particlesize. Am J Respir Crit Care Med, 2005, 172: 1497-1504.
27. Usmani O. Treating the Small Airways. Respiration, 2012, 84: 441-453.
28. Leach CL, Kuehl PJ, Chand R, McDonald JD. Respiratory Tract Deposition of HFABeclomethasone and HFA-Fluticasone in Asthmatic Patients. J Aerosol Med Pulm Drug Deliv, 2016 Apr, 29(2): 127-133.
29. De Backer W et al. Lung deposition of BDP/for-moterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv, 2010 Jun, 23(3): 137-148.
30. Huchon G et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med, 2009 Jan, 103(1): 41-49.
31. Price D et al. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma. Respir Med, 2013 Jul, 107(7): 987-1000.
32. De Backer J et al. The Effects of Extrafine Beclometasone/Formoterol (BDP/F) on Lung Function, Dyspnea, Hyperinflation, and Airway Geometry in COPD Patients: Novel Insight Using Functional Respiratory Imaging. J Aerosol Med Pulm Drug Deliv, 2015 Apr, 28(2): 88-99. doi: 10.1089/jamp.2013.1064. Epub 2014 Jul 8.
33. Mutch E et al. The role of esterases in the metabolism of ciclesonide to desisobutyrylciclesonide in human tissue. Biochem Pharmacol, 2007, 73: 1657-1666.
34. Dietzel K et al. Ciclesonide: an on-site activated steroid. Prog Respir Res, 2001, 31: 91-93.
35. Leach CL et al. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. J Aerosol Med, 2006, 19: 117-126.
36. Newman S et al. High lung deposition of 99mTclabeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med, 2006, 100: 375-384.
37. Cohen J et al. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J, 2008 Jun, 31(6): 1213-1220.
38. Hoshino M et al. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. Allergology International, 2010, 59: 59-66.
39. Zietkowski Z et al. Effect of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma. Respir Med, 2006, 100: 1651-1656.
40. Van der Molen T et al. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. BMC Pulm Med, 2016 May 17, 16(1): 80.
41. Postma D et al. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy Asthma Immunol Res, 2017 Mar, 9(2): 116-112.
42. Bateman ED et al. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Pulm Pharmacol Ther, 2008, 21: 264-275.
43. Derom E et al. Effects of inhaled ciclesonide and fluticasone proprionate on cortisol secretion and airway responsiveness to adenosine 5’monophosphate in asthmatic patients. Pulm Pharmacol Ther, 2005, 18: 328-336.
Review
For citations:
Fassakhov RS. SIGNIFICANT ROLE OF SMALL RESPIRATORY TRACTS: NEW POSSIBILITIES OF CYCLESONIDE IN THERAPY OF BRONCHIAL ASTHMA. Meditsinskiy sovet = Medical Council. 2017;(18):56-60. (In Russ.) https://doi.org/10.21518/2079-701X-2017-18-56-60
Views:
784
Email this article 